TriSalus Life Sciences
TLSI
TLSI
72 hedge funds and large institutions have $225M invested in TriSalus Life Sciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
72
Holders Change
–
Holders Change %
0%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
14
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FTCM
1
First Trust Capital Management
Chicago,
Illinois
|
$7.09M |
| 2 |
MSU
2
Mizuho Securities USA
New York
|
$4.51M |
| 3 |
AA
3
AQR Arbitrage
Greenwich,
Connecticut
|
$3.98M |
| 4 |
4
Jane Street
New York
|
$6.53M |
| 5 |
BFM
5
Boothbay Fund Management
New York
|
$2.06M |
Top Sellers
| 1 |
KC
1
Kryger Capital
London,
United Kingdom
|
$5.12M |
| 2 |
AC
2
Antara Capital
New York
|
$0 |
| 3 |
MF
3
Magnetar Financial
Evanston,
Illinois
|
$12.7M |
| 4 |
4
Millennium Management
New York
|
$1.66M |
| 5 |
5
Goldman Sachs
New York
|
$1.35M |